Industry News
NABP Accused of Enforcing ‘Shadow Regulation’ Twice in 3 years

Licensing Issues Causes Public Skirmish with State Boards for Drug Companies

The patchwork that is state licensure is a constant challenge for all companies in the pharmaceutical supply chain – from international drug manufacturers to independent distributors. Companies not in compliance are at significant risk of being caught by state agencies and facing significant fines, having disciplinary action follow them for years, and, in one example, being forced to close their business. Most important to remember is that non-compliance typically sets off a chain reaction.

read more

Email Newsletter